BRIDGEBIO PHARMA INC. - COMMON STOCK
23.42
22-十一月-24 16:44:58
15 分钟延时
股票
+0.18
+0.77%
今日范围
22.47 - 23.65
ISIN
N/A
来源
NASDAQ
-
22 11月 2024 19:11:30 条件 Nasdaq GlobeNewswire
-
18 11月 2024 11:15:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Third Quarter 2024 Financial Results and Business Update
12 11月 2024 07:30:01 条件 Nasdaq GlobeNewswire
-
05 11月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
24 10月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
30 9月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
17 9月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
10 9月 2024 16:45:00 条件 Nasdaq GlobeNewswire
-
10 9月 2024 16:45:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06 9月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
30 8月 2024 10:50:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma to Participate in September Investor Events
28 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Launches MyAchonJourney, a New Resource for Families Navigating Achondroplasia
19 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update
01 8月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
BridgeBio Announces Appointment of Thomas Trimarchi, Ph.D., as President and Chief Operating Officer
23 7月 2024 07:30:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >